ETOPERIDONE HYDROCHLORIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H28ClN5O.ClH
Molecular Weight	414.372
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.CCN1C(=O)N(CCCN2CCN(CC2)C3=CC=CC(Cl)=C3)N=C1CC

InChI

InChIKey=BHKPQZVLIZKSAG-UHFFFAOYSA-N

InChI=1S/C19H28ClN5O.ClH/c1-3-18-21-25(19(26)24(18)4-2)10-6-9-22-11-13-23(14-12-22)17-8-5-7-16(20)15-17;/h5,7-8,15H,3-4,6,9-14H2,1-2H3;1H

HIDE SMILES / InChI

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C19H28ClN5O
Molecular Weight	377.912
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11765144 | https://www.ncbi.nlm.nih.gov/pubmed/12487725 | https://www.ncbi.nlm.nih.gov/pubmed/29053130 | https://www.ncbi.nlm.nih.gov/pubmed/7766726 |

Etoperidone is an atypical antidepressant introduced in Europe in 1977. The activity of etoperidone is made mainly by its major metabolite 1-(3'-chlorophenyl)piperazine (mCPP). mCPP binds with different affinity to most of the serotonergic receptors and adrenergic receptors. This metabolite is an agonist of 5-HT2c and an antagonist of 5-HT2a. Part of etoperidone structure contributes to the activity in the α-adrenergic receptors. Etoperidone has been studied for the treatment of depression, tremors in Parkinson, extrapyramidal symptoms and male impotence. It is not certain if it was ever approved and marketed but its current status is withdrawn.

Approval Year

Targets

Primary Target	Pharmacology	Potency
Adrenergic receptor alpha-1 169 Target ID: CHEMBL2094251 Sources: https://www.drugbank.ca/drugs/DB09194	Antagonist 2778	38.0 nM [Kd]
Adrenergic receptor alpha-2 113 Target ID: CHEMBL2095158 Sources: https://www.drugbank.ca/drugs/DB09194	Antagonist 2778	570.0 nM [Kd]
Dopamine D2 receptor 297 Target ID: CHEMBL217 Sources: https://www.drugbank.ca/drugs/DB09194\|http://drugcentral.org/drugcard/1111	Antagonist 2778	2.3 µM [Kd]
Serotonin 1a (5-HT1a) receptor 172 Target ID: CHEMBL214 Sources: https://www.drugbank.ca/drugs/DB09194\|http://drugcentral.org/drugcard/1111	Antagonist 2778	85.0 nM [Kd]
Serotonin 2 (5-HT2) receptor 87 Target ID: CHEMBL2095200 Sources: https://www.drugbank.ca/drugs/DB09194\|http://drugcentral.org/drugcard/1111	Antagonist 2778	36.0 nM [Kd]

PubMed

Title	Date	PubMed
Thioridazine for dementia.	2001	11686961
Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.	2008 Aug 19	18665165

Patents

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:12:07 GMT 2023` Edited by `admin` on `Fri Dec 15 16:12:07 GMT 2023`
Record UNII	2FSU2FR80J
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ETOPERIDONE HYDROCHLORIDE

Official Name

English

3H-1,2,4-TRIAZOL-3-ONE, 2-(3-(4-(3-CHLOROPHENYL)-1-PIPERAZINYL)PROPYL)-4,5-DIETHYL-2,4-DIHYDRO-, MONOHYDROCHLORIDE

Common Name

English

ETOPERIDONE HCL

Common Name

English

ETONIN

Brand Name

English

DEPRACER

Brand Name

English

AXIOMIN

Brand Name

English

Etoperidone hydrochloride [WHO-DD]

Common Name

English

ETOPERIDONE HYDROCHLORIDE [MART.]

Common Name

English

ETOPERIDONE HYDROCHLORIDE [USAN]

Common Name

English

ETORAN

Brand Name

English

TROPENE

Systematic Name

English

ETOPERIDONE HYDROCHLORIDE [MI]

Common Name

English

MCN-A-2673-11

Code

English

1-(3-(4-(M-CHLOROPHENYL)-1-PIPERAZINYL)PROPYL)-3,4-DIETHYL-D2-1,2,4-TRIAZOLIN-5-ONE MONOHYDROCHLORIDE

Common Name

English

NSC-304398

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C267